[ad_1]
And Secretary of Health. Abdul Mannan said they expected the vaccine to arrive in the country in February, subject to approval of the deal by the World Health Organization.
The minister and secretary spoke to reporters after a meeting on the coronavirus vaccine at the secretariat on Monday.
The government of Bangladesh signed an agreement with the Serum Institute of India on November 5 to purchase 30 million doses of the Oxford-AstraZeneca vaccine. Under the agreement, the Seram Institute will ship 5 million doses of Ticker each month.
If the Indian pharmaceutical regulator approves the emergency use of the vaccine on Sunday, hopes for a rapid vaccine in Bangladesh are high, as the health minister has said that if India approves it, Bangladesh will receive the first shipment of the Oxford vaccine. in january.
But Adar Poonawala, executive director of the Seram Institute, was quoted in various international media outlets Sunday night as saying that they would insist on meeting local demand from India for the next two months before exports could begin. Following his statement, it was feared that Bangladesh’s vaccination would be delayed.
As a result, journalists wanted to know from the Minister of Health whether vaccination would be delayed in Bangladesh.
He replied: “I have been working on this issue since morning. Talks have been held with Beximco, the Ministry of Foreign Affairs and the Indian Mission. They assured that the agreement reached with us will not be affected. There will be no problem, we continue the discussion “.
Beximco Pharmaceuticals Limited is responsible for importing vaccines from India and supplying them to Bangladesh. They are the “exclusive distributor” of vaccines produced at the Seram Institute in Bangladesh.
Rabbur Reza, COO of Beximco Pharmaceuticals, told bdnews24.com that they had no doubts about the vaccine.
“According to our agreement with the Seram Institute, we will get the first batch of vaccines within a month after the vaccine is approved in Bangladesh.”
He said they had submitted documents to the Department of Drug Administration last Thursday for approval of Oxford-AstraZeneca’s Covishield vaccine, produced at the Serum Institute of India. On Monday they will request the approval of the ticker.
However, the Minister of Health is also talking about a condition for obtaining permission from the World Health Organization.
“According to the agreement, the WHO will vaccinate us only if it gives us permission. We will receive the vaccine as discussed. This agreement is international, so we have confidence in it. We are optimistic about everything.”
Under the deal, the process of shipping £ 120 million for the vaccine is moving very quickly and the money will be deposited on Tuesday, he said. It cannot be said right now, I will be able to report in two or four days ”.
The Minister said that talks have been held with several countries on the issue of vaccines. If the trial doesn’t end, no settlement can be reached. Discussions have been held with China and detailed documents have been requested from them. ”
Secretary of the Department of Health after the Minister’s speech. Abdul Mannan said: “I just called (at noon) the Deputy High Commissioners of India. He told us that the agreement we made, … his financial transaction, how the money will go, how the bank will give a guarantee, all those things have been done by GTZ or the government to the government. The ban that has been mentioned, the government of India has said only about business activities, not about us. Because ours is from government to government. “
Assuring that there is “no fear” about the vaccine, the secretary said: “The Seram Institute of India has received approval from the Government of India. Once approved, they will go to WHO for approval, which will take about three weeks. Our time was called pub in February. After these three weeks, that is, there is no time to delay. There is still nothing to worry about. The issue of sending money has been finalized today and is being sent. ”
[ad_2]
